Nathan Singh, MD, MS

Medical Oncologist

Nathan Singh

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

Expertise & Training

Clinical Expertise

  • Leukemia, hematopoietic cell transplantation

Primary Academic Title

Associate Professor of Medicine, Division of Oncology, WashU Medicine

Board Certification

  • 2017: American Board of Internal Medicine

Training

  • 2014 - 2016: Resident, Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
  • 2016 - 2019: Fellow, Hematology and Oncology, University of Pennsylvania Health System, Philadelphia, PA

Education

  • 2013: MD, University of Pennsylvania, Philadelphia, PA
  • 2013: MS, University of Pennsylvania, Philadelphia, PA

Research & Selected Publications

Research Interest

Understanding how blood cancers resist cellular immunotherapy by causing dysfunctional activity of adoptively transferred T cells.

Research Publications

BACH2 regulates T cell lineage state to enhance CAR T cell function
Authors:

Chang TC, Heard A, Lattin J, one or more additional authors omitted Singh N

Journal & Year:

Nat Immunol | 2026

Disarming myeloid resistance in CAR T therapy
Authors:

Warrington JM, Singh N

Journal & Year:

Cancer Cell | 2025

Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
Authors:

Chang JF, Landmann JH, Chang TC, one or more additional authors omitted Singh N

Journal & Year:

Cancer Discov | 2024

Regulatory Considerations for Genome-Edited T-cell Therapies
Authors:

Jadlowsky JK, Chang JF, Spencer DH, one or more additional authors omitted Singh N

Journal & Year:

Cancer Immunol Res | 2024

Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
Authors:

Chang JF, Wellhausen N, Engel NW, one or more additional authors omitted Singh N

Journal & Year:

Cancer Immunol Res | 2024

Analysis of pre-treatment tumors reveals gatekeepers of response to CAR T cells
Authors:

Singh N

Journal & Year:

Mol Ther | 2024

Synthetic manipulation of the cancer-immunity cycle: CAR-T cell therapy
Authors:

Singh N, Maus MV

Journal & Year:

Immunity | 2023